Revive Financial Statements From 2010 to 2025
| RVVTF Stock | USD 0.01 0 20.00% |
Check Revive Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Revive Therapeutics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Revive financial statements analysis is a perfect complement when working with Revive Therapeutics Valuation or Volatility modules.
Revive |
Revive Therapeutics OTC Stock Return On Equity Analysis
Revive Therapeutics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Revive Therapeutics Return On Equity | -0.83 |
Most of Revive Therapeutics' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Revive Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Revive Therapeutics has a Return On Equity of -0.8286. This is 96.54% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The return on equity for all United States stocks is 167.29% higher than that of the company.
Revive Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Revive Therapeutics's current stock value. Our valuation model uses many indicators to compare Revive Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Revive Therapeutics competition to find correlations between indicators driving Revive Therapeutics's intrinsic value. More Info.Revive Therapeutics is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Revive Therapeutics' earnings, one of the primary drivers of an investment's value.About Revive Therapeutics Financial Statements
Revive Therapeutics stakeholders use historical fundamental indicators, such as Revive Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Revive Therapeutics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Revive Therapeutics' assets and liabilities are reflected in the revenues and expenses on Revive Therapeutics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Revive Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company was incorporated in 2012 and is headquartered in Toronto, Canada. Revive Therapeutics is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in Revive OTC Stock
Revive Therapeutics financial ratios help investors to determine whether Revive OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Revive with respect to the benefits of owning Revive Therapeutics security.